Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis
Abstract
Despite the widespread prescribing of benzodiazepines, uncertainty still surrounds the potential for cognitive impairment following their long-term use. Furthermore, the degree of recovery that may take place after withdrawal or the level of residual impairment, if any, that is maintained in long-term benzodiazepine users is also unclear. The current paper employed meta-analytic techniques to address two questions: (1) Does the cognitive function of long-term benzodiazepine users improve following withdrawal? (2) Are previous long-term benzodiazepine users still impaired at follow-up compared to controls or normative data? Results of the meta-analyses indicated that long-term benzodiazepine users do show recovery of function in many areas after withdrawal. However, there remains a significant impairment in most areas of cognition in comparison to controls or normative data. The findings of this study highlight the problems associated with long-term benzodiazepine therapy and suggest that previous benzodiazepine users would be likely to experience the benefit of improved cognitive functioning after withdrawal. However, the reviewed data did not support full restitution of function, at least in the first 6 months following cessation and suggest that there may be some permanent deficits or deficits that take longer than 6 months to completely recover.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 17 cited sources checked · 0 supported · 0 flagged
- Findingown data
Weighting for sample size had little impact on the effect size (0.42 unweighted compared to 0.40 weighted, meta-analysis A; -0.41 unweighted compared to -0.48 weighted, meta-analysis B).
“Weighting for sample size had little impact on the effect size (0.42 unweighted compared to 0.40 weighted, meta-analysis A; -0.41 unweighted compared to -0.48 weighted, meta-analysis B)”
Quote in the paperNot a substantial claim - Findingown data
Analyses of moderator variables did not reveal any significant relationships.
“An analyses conducted on moderator variables did not reveal any significant relationships.”
Quote in the paperNot a substantial claim - Findingown data
There remains a significant impairment in most areas of cognition in long-term benzodiazepine users at follow-up compared to controls or normative data.
“However, there remains a significant impairment in most areas of cognition in comparison to controls or normative data.”
Quote in the paperSubstantial claim - Findingown data
The mean weighted effect size for cognitive improvement after withdrawal (meta-analysis A) was 0.41 (median = 0.37, SD = 0.22).
“The mean weighted effect size was 0.41 (median = 0.37) with a standard deviation of 0.22.”
Quote in the paperSubstantial claim - Findingown data
In meta-analysis A, effect sizes greater than zero were found across all cognitive domains measured.
“In meta-analysis A, effect sizes greater than zero were found across all cognitive domains measured”
Quote in the paperSubstantial claim
- Findingown data
There was a significant negative correlation between age and overall effect size.
“The significant negative correlation, between age and overall effect size, suggests that improvement in attention/concentration after withdrawal decreases as age increases.”
Quote in the paperNot a substantial claim - Findingown data
Negative effect sizes were found across 11 of the 12 cognitive categories in meta-analysis B.
“Negative effect sizes were found across 11 of the 12 cognitive categories in meta-analysis B”
Quote in the paperSubstantial claim - Findingown data
Long-term benzodiazepine users show recovery of cognitive function in many areas after withdrawal.
“Results of the meta-analyses indicated that long-term benzodiazepine users do show recovery of function in many areas after withdrawal.”
- Also stated in: § 2.1. Meta-analysis A: Does the cognitive function of long-term benzodiazepine users improve following withdrawal? · hedged
“Compared to their initial assessment, previous long-term benzodiazepine users appeared to improve across all cognitive categories examined at follow-up assessment.”
Quote in the paperSubstantial claim - Also stated in: § 2.1. Meta-analysis A: Does the cognitive function of long-term benzodiazepine users improve following withdrawal? · hedged
- Findingown data
The reviewed data did not support full restitution of cognitive function, at least in the first 6 months following benzodiazepine cessation.
“However, the reviewed data did not support full restitution of function, at least in the first 6 months following cessation”
Quote in the paperSubstantial claim - Findingown data
Compared to controls or norms, previous long-term benzodiazepine users performed more poorly across all cognitive categories except sensory processing at follow-up assessment.
“Compared to controls or norms, previous long-term benzodiazepine users performed more poorly across all cognitive categories, except sensory processing, when examined at follow-up assessment.”
- Also stated in: § 3. Discussion · hedged
“suggesting that, except for sensory processing, patients who had withdrawn from long-term benzodiazepine use continued to perform more poorly than controls (or normative data) at follow-up.”
Quote in the paperSubstantial claim - Also stated in: § 3. Discussion · hedged
- Findingown data
There was a significant negative correlation between mean age and attention/concentration effect size (r(8) = -.72, P < .05).
“an analysis conducted on moderator variables revealed one significant correlation between mean age and attention/concentration, r (8) = -.72,P < .05”
Quote in the paperNot a substantial claim - Findingown data
Many of the 95% confidence intervals in this meta-analysis did not span zero.
“and many of the 95% confidence intervals did not span zero.”
Quote in the paperSubstantial claim - Findingown data
No other variables examined in either meta-analysis were found to be significantly related to any of the individual cognitive domain effect sizes, nor to the overall effect size.
“As expected, no other variables examined in either meta-analysis were found to be significantly related to any of the individual cognitive domain effect sizes, nor to the overall effect size.”
Quote in the paperNot a substantial claim - Findingown data
In meta-analysis B, effect sizes ranged in magnitude from -1.50 to 0.26.
“Effect sizes ranged in magnitude from -1.50 to 0.26.”
Quote in the paperNot a substantial claim - Findingown data
Some degree of improvement in cognitive function after withdrawal was observed.
“some degree of improvement in cognitive function after withdrawal was observed”
Quote in the paperSubstantial claim - Findingown data
Closer examination of studies published later than 1994 did not reveal any obvious differences in any participant or study variables compared to earlier published studies.
“Closer examination of studies published later than 1994 did not reveal any obvious differences in any participant or study variables compared to earlier published studies.”
Quote in the paperNot a substantial claim - Interpretationown data
Following withdrawal from long-term benzodiazepine use, patients show improvement or significant recovery of cognitive function in many areas.
“suggesting that improvement in cognitive function does occur following withdrawal from long-term benzodiazepine use.”
- Also stated in: § 3. Discussion · hedged
“The current meta-analyses go further to suggest that these patients do show significant recovery of function in many areas after withdrawal.”
Quote in the paperSubstantial claim - Also stated in: § 3. Discussion · hedged
- Study design and conductown data
The small number of studies included in the meta-analysis resulted in insufficient data to conduct a thorough investigation of the contribution of moderator variables.
“The small number of studies included in the meta-analysis also resulted in insufficient data to conduct a thorough investigation of the contribution of moderator variables.”
Quote in the paperSubstantial claim - Premisenone given
Research into the residual cognitive effects after long-term benzodiazepine use yields conflicting results.
“However, research into the residual cognitive effects after long-term use yields conflicting results.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Birzele, 1992
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Chaves, Bianchin, Peccin, & Rotta, 1993 source
- cites Lucki & Rickels, 1986
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
The conservative approach to effect size calculation combined with the small sample of studies may have resulted in an underestimation of the true effect size.
“In addition, the conservative approach to effect size calculation that was adopted, combined with the small sample of studies, may have resulted in an underestimation of the true effect size.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The effect sizes found in this meta-analysis were substantial across most cognitive domains.
“The effect sizes found in this meta-analysis were substantial across most domains”
Quote in the paperSubstantial claim - Premisecitation
Gorenstein et al. (1995) found that performance did not significantly improve after an average of 10 months abstinence in 18 previous low-dose benzodiazepine users of more than 5 years.
“Performance did not significantly improve after an average of 10 months abstinence on tests such as digit-symbol-substitution, digit span and immediate and delayed recall.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Gorenstein, Bernik, Pompeia, and Marcourakis (1995) source
- Interpretationown data
As age increases, post-withdrawal recovery decreases on tasks of attention/concentration.
“suggesting that as age increases, post-withdrawal recovery decreases on tasks of attention/concentration.”
Quote in the paperSubstantial claim - Interpretationown data
Improvement in attention/concentration after withdrawal decreases as age increases.
“The significant negative correlation, between age and overall effect size, suggests that improvement in attention/concentration after withdrawal decreases as age increases.”
Quote in the paperSubstantial claim - Premisecitation
Sakol and Power (1988) observed improvements in attention, vigilance, and speed of information processing in 12 long-term benzodiazepine users after graded withdrawal.
“Sakol and Power (1988) studied 12 long-term benzodiazepine users (mean use 9 years) before and after graded withdrawal and observed improvements in tasks assessing attention, vigilance, and speed of information processing.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sakol & Power, 1988 source
- Premisecitation
Tata et al. (1994) found that chronic benzodiazepine users followed up 6 months after successful discontinuation displayed significant impairments in verbal learning and memory, psychomotor, visuomotor, and visuoconceptual abilities compared to controls.
“Tata et al.'s (1994) group of chronic benzodiazepine users followed up 6 months after successful discontinuation displayed significant impairments in verbal learning and memory, psychomotor, visuomotor, and visuoconceptual abilities compared to controls.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Tata et al., 1994 source
- Premisecitation
Rickels et al. (1999) found that successful taper patients displayed improved performance on a digit-symbol-substitution test and a symbol copy task.
“Successful taper patients displayed improved performance on a digit-symbol-substitution test and a symbol copy task”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Rickels, Lucki, Schweizer, Garcia-Espana, and Case (1999) source
- Premisecitation
Because studies that obtain non-significant results are less likely to be published, extracting data from only published results is likely to bias results in favor of a significant mean effect size.
“Because studies that obtain non-significant results are less likely to be published, extracting data from only published results is likely to bias results in favor of a significant mean effect size (Rosenthal, 1991).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Rosenthal, 1991
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Salzman et al. (1992) reported that cognitive impairment in nursing home residents was reversed after withdrawal.
“Salzman, Fisher, Nobel, and Glassman (1992) reported that cognitive impairment observed in their samples of 13 nursing home residents was reversed after withdrawal as compared to the 12 residents who did not withdraw.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Salzman, Fisher, Nobel, and Glassman (1992) source
- Interpretationown data
Previous benzodiazepine users would be likely to experience improved cognitive functioning after withdrawal.
“suggest that previous benzodiazepine users would be likely to experience the benefit of improved cognitive functioning after withdrawal.”
Quote in the paperSubstantial claim - Interpretationown data
The inclusion of studies with small samples that yielded large effect sizes did not artificially increase the effect size.
“suggesting that the inclusion of studies with small samples that yielded large effect sizes did not artificially increase the effect size.”
Quote in the paperSubstantial claim - Interpretationown data
Previous long-term benzodiazepine use may lead to impairments in cognition.
“Although these findings suggest that previous long-term benzodiazepine use may lead to impairments in cognition”
Quote in the paperSubstantial claim - Interpretationown data
There remains a significant impairment in most areas of cognition compared to controls or normative data.
“However, there remains a significant impairment in most areas of cognition compared to controls or normative data.”
Quote in the paperSubstantial claim - Premisecitation
In Gorenstein et al.'s (1995) study, despite similar anxiety levels, poorer performance of chronic benzodiazepine users compared to anxious controls could not be attributed to the anxiety disorder itself.
“The anxious control group was also compared to chronic benzodiazepine users and it was concluded that, despite similar anxiety levels, poorer performance could not be attributed to the anxiety disorder itself.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Gorenstein et al. (1995) source
- Premisecitation
Results of previous research support the notion that the observed deficits may be unrelated to patients' psychiatric symptomology.
“Although this explanation must be considered, results of previous research support the notion that the observed deficits may be unrelated to patient's psychiatric symptomology.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Gorenstein et al. (1995) source
- Interpretationown data
Data from this study do not support a full recovery, at least in the first 6 months following cessation.
“However, data from this study do not support a full recovery, at least in the first 6 months following cessation”
Quote in the paperSubstantial claim - Interpretationown data
Previous benzodiazepine users are likely to experience the benefit of improved cognitive functioning after withdrawal.
“suggesting that previous benzodiazepine users are likely to experience the benefit of improved cognitive functioning after withdrawal.”
Quote in the paperSubstantial claim - Interpretationown data
It is unlikely that the observed deficits are a function of increased anxiety levels caused by withdrawal of medication.
“It is also unlikely that the observed deficits may be a function of increased anxiety levels caused by withdrawal of medication.”
Quote in the paperSubstantial claim
- Classified as probably not a substantial claim. 16
- May combine two claims. 23
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataStudies published later than 1994 tended to have larger effect sizes.
“One trend of interest was a relationship between publication year and overall effect size, such that studies published later than 1994 tended to have larger effect sizes.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn meta-analysis B, the mean weighted effect size was -0.48 (median = 0.48) with a standard deviation of 0.45.
“The mean weighted effect size was -0.48 (median = 0.48) with a standard deviation of 0.45.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based).
Findingnone givenThe studies included in these meta-analyses were all published in peer-reviewed journals.
“The studies included in these meta-analyses were all published in peer-reviewed journals.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe fail-safe n was calculated to be four for meta-analysis A and five for meta-analysis B.
“The fail-safe n, which represents the number of studies obtaining null results that would need to be in existence to threaten the significant effect size found, was calculated to be four for meta-analysis A and five for meta-analysis B.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn meta-analysis B, the 95% confidence intervals did not span zero for 8 of the 11 effect sizes, so most of these effects are significant and different from zero.
“It is clear from Fig. 2 that the 95% confidence intervals do not span zero for 8 of the 11 effect sizes and therefore, that most of these effects are significant and different to zero”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe 95% confidence intervals did not span zero for 5 of 11 effect sizes, indicating significant improvement in those cognitive categories.
“It is clear from Fig. 1 that the 95% confidence intervals do not span zero for 5 of 11 effect sizes and therefore, that these effects are significant and different from zero”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataIn meta-analysis B, from nine studies covering 12 cognitive categories, 37 effect sizes were obtained.
“From nine studies covering 12 categories (a maximum of 108 possible effect sizes), 37 effect sizes were obtained.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingreasoningIn the present meta-analyses, the tolerance level is estimated at 60 for meta-analysis A and 55 for meta-analysis B.
“In the present meta-analyses, the tolerance level is estimated at 5(10) + 10 = 60 and 5(9) + 10 = 55 for meta-analyses A and B, respectively.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAll effect sizes for cognitive improvement after withdrawal were positive, ranging from 0.06 to 0.70.
“All of the effect sizes were positive and ranged in magnitude from 0.06 to 0.70.”
Quote in the paperSubstantial claimMay combine two claims.
Findingnone givenMean scale scores in four of these six studies would be considered in the clinical range and two in the non-clinical range.
“Mean scale scores in four of these would be considered in the clinical range and two in the non-clinical range.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe degree of recovery in attention/concentration is significant with a moderate to large effect size (d = 0.69), and the level of residual impairment is significant with a small to moderate effect size (d = -0.43).
“For example, the degree of recovery that appears to take place in the domain of attention/concentration is significant with a moderate to large effect size (d = 0.69), and a significant, small to moderate effect size (d = -0.43)indicating the level of residual impairment.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSeven out of 10 studies reported pre- and post-withdrawal anxiety or depression levels, and in all of these, patients' symptoms either improved significantly or remained the same.
“Seven out of 10 studies reported pre-and post-withdrawal anxiety or depression levels and in all of these, patient's symptoms either improved significantly or remained the same.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataSix studies specified pre- and post-withdrawal psychiatric symptoms using a variety of subjective mood scales.
“Six studies specified pre-and post-withdrawal psychiatric symptoms using a variety of subjective mood scales including the Spielberger State-Trait Anxiety Inventory, the Hamilton Anxiety Scale, the Hamilton Depression Scale, and the Beck Depression Inventory.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataIt was not possible to calculate effect sizes for all 12 categories because only one test within the problem-solving category was used.
“it was not possible to calculate effect sizes for all 12 categories as only one test within the problem-solving category was used”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataFive studies specified the conditions for which subjects used benzodiazepines, and for all five the conditions were anxiety or depression.
“Five studies specified the conditions for which subjects used benzodiazepines and for all five the conditions were anxiety or depression.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataEight studies excluded patients with a history of heavy alcohol or other drug use, and one study stated that 23% of patients had a history of alcohol use in excess of four standard drinks per day.
“Eight studies excluded patients with a history of heavy alcohol or other drug use and one study stated that 23% of patients had a history of alcohol use in excess of four standard drinks per day.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAll six studies reported that mean scores either remained the same following withdrawal (four studies) or significantly improved (two studies).
“All six studies reported that mean scores either remained the same following withdrawal (four studies) or significantly improved (two studies).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningThe significant negative correlation between age and overall effect size should be interpreted with caution due to the inflation in type I error rate associated with the number of analyses conducted.
“However, it should be interpreted with caution due to the inflation in type I error rate associated with the number of analyses conducted.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThere may be some permanent cognitive deficits, or deficits that take longer than 6 months to completely recover, after long-term benzodiazepine use.
“and suggest that there may be some permanent deficits or deficits that take longer than 6 months to completely recover.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenA conservative approach was adopted for coding significance levels in the meta-analysis.
“With regard to the coding of significance levels, a conservative approach was adopted.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationAccording to Cohen (1988), effect sizes of d = 0.20, 0.50, and 0.80 are considered small, medium, and large in magnitude, respectively.
“According to Cohen (1988), effect sizes of d = 0.20, 0.50, and 0.80 are considered small, medium, and large in magnitude, respectively.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Cohen (1988)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Classified as probably not a substantial claim. May combine two claims.
Study design and conductreasoningEach study was allowed to contribute only one effect size to each cognitive category by averaging effect sizes from multiple tests, giving equal weight to each study per category.
“Each study was only allowed to contribute one effect size to each cognitive category by averaging together the effect sizes from the same study if more than one type of test was used to measure a particular category.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenEffect sizes were weighted on the basis of their sample size.
“Effect sizes were weighted on the basis of their sample size.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationRosenthal has suggested that a conservative estimate for the tolerance level is 5k + 10 where k is the number of studies retrieved.
“Rosenthal has suggested that a conservative estimate for this tolerance level is 5k + 10 where k is the number of studies retrieved.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Rosenthal
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Interpretationown dataSince the fail-safe n falls short of the tolerance level, the possibility of a file drawer problem should be considered for both meta-analyses, and the resulting effect sizes interpreted with caution.
“Since the fail-safe n falls short of the tolerance level, the possibility of a file drawer problem should be considered for both meta-analyses, and the resulting effect sizes interpreted with caution.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationThe finding that improvement in attention/concentration after withdrawal decreases with age may be related to deficits in performance on tasks of attention and concentration observed to accompany normal aging.
“This finding may be related to deficits in performance on tasks of attention and concentration observed to accompany normal aging (Lezak, 1995).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lezak, 1995
May combine two claims.
PremisecitationIn a previous meta-analysis by the authors, moderate to large effect sizes were found across all cognitive areas studied, indicating that long-term benzodiazepine users are impaired across many cognitive areas.
“In a previous meta-analysis that we have conducted looking at the long-term cognitive effects of benzodiazepine use (Barker, Greenwood, Jackson & Crowe, in press) we found moderate to large effect sizes across all cognitive areas studied indicating that long-term benzodiazepine users are impaired across many cognitive areas.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Barker, Greenwood, Jackson & Crowe, in press
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
InterpretationreasoningIt seems unlikely that a dementing process contributed to the cognitive deficits, given that the mean age in nine studies was between 39 and 47 years, and the remaining study screened for and excluded patients with dementia.
“This seems unlikely, however, given that the mean age in nine of the studies was between 39 and 47 years, and the remaining study, which examined mainly older adults, did in fact screen for and exclude patients with dementia.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
InterpretationreasoningIt may be the case that some real differences exist that were undetectable given the small sample size.
“It may be the case that some real differences do exist that were undetectable given the small sample size.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataThere may be some permanent deficits or deficits that take periods longer than 6 months to completely recover.
“and suggests that there may be some permanent deficits or deficits that take periods longer than 6 months to completely recover.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataDue to the small number of studies that met inclusion criteria and the limited information provided on relevant characteristics, an analysis of heterogeneity (Q) was considered inappropriate.
“Due to the small number of studies that met inclusion criteria in this meta-analysis, and the limited information provided on relevant characteristics, an analysis of heterogeneity (Q) (Hedges & Olkin, 1985) was considered inappropriate.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hedges & Olkin, 1985
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationGorenstein et al.'s (1995) well-controlled comparison of neuropsychological test performance in anxious drug-free patients and normal controls found no significant difference in performance on a variety of neuropsychological tests except for a ball-bearing test measuring motor co-ordination.
“Gorenstein et al.'s (1995) well-controlled comparison of neuropsychological test performance in anxious drug-free patients and normal controls found no significant difference in performance on a variety of neuropsychological tests except for a ball-bearing test measuring motor co-ordination.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Gorenstein et al. (1995) source
May combine two claims.
InterpretationreasoningIntegrating all available evidence indicates that long-term benzodiazepine users may be affected in a generalized rather than specific way, with some areas being more affected than others.
“integrating all of the available evidence indicates that long-term benzodiazepine users may be affected in a generalized rather than specific way, with some areas being more affected than others.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductnone givenThe presence or absence of dementia in older subjects was not typically reported, and the possibility of a dementing process as a contributing factor to the cognitive deficits observed cannot be ruled out.
“The presence or absence of dementia in older subjects was not typically reported and the possibility of a dementing process as a contributing factor to the cognitive deficits observed cannot be ruled out.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
Little is known regarding the potential long-term effects of benzodiazepines.
“Despite such widespread use, little is known regarding the potential long-term effects of benzodiazepines.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In a meta-analysis, Barker et al. concluded that long-term benzodiazepine users show recovery of function in visuospatial skills, attention/concentration, general intelligence, psychomotor speed, and nonverbal memory after withdrawal.
“In a metaanalysis, Barker et al. (170) concluded that longterm BZD users show recovery of function in visuospatial skills, attention ⁄ concentration, general intelligence, psychomotor speed and nonverbal memory assessments after withdrawal.”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [170]
The study data did not demonstrate complete restoration of function within the first 6 months after discontinuation of benzodiazepine use.
“The authors reported that the study data did not demonstrate complete restoration of function within the first 6 months following discontinuation of BZD use”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [170]
Longer than 6 months may be needed for recovery from some deficits after benzodiazepine discontinuation.
“they suggested that longer than 6 months may be needed for recovery from some deficits.”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [170]
For long-term benzodiazepine users, the possible degree of recovery and the extent of residual impairment after withdrawal are unclear.
“For individuals who use BZDs long term, the possible degree of recovery and the extent of residual impairment that may remain after the drugs are withdrawn are unclear (170).”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [170]
The same authors found that significant cognitive impairment was more persistent in long-term users than in control groups or normative data.
“The authors found, however, that significant cognitive impairment was more persistent in long-term users than in control groups or in normative data.”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [170]
Compelling evidence does not support full restitution of cognitive function at least in the first 6 months after benzodiazepine cessation, and there is a suggestion of some permanent deficits compared with controls.
“compelling evidence not supporting full restitution of cognitive function, at least in the first 6 months after cessation, and suggestion that there may be some permanent deficits in comparison to controls (Barker et al., 2004).”
From A Review of Alprazolam Use, Misuse, and Withdrawal (2018) · cites this paper as Barker et al., 2004
Loss of memory associated with benzodiazepine use may be lasting, even after treatment discontinuation, although other studies reported improved cognitive functioning after discontinuation.
“A major concern is that loss of memory associated with benzodiazepine use may be lasting, even after treatment discontinuation [62, 63], although other studies reported improved cognitive functioning after discontinuation with increased speed and accuracy of information processing, improved reaction time and working memory [50, 64–66].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [63]
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- Consistentr(8) = -0.72reported p < .05 · recomputed p = .019
“r (8) = -.72,p < .05”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Two weighted overall effects are given for meta-analysis A
MinorThe discussion gives 0.40 as the weighted effect, while Table 3 and the results section give 0.41.
“0.42 unweighted compared to 0.40 weighted, meta-analysis A”
“| Overall | 44 | 0.42 | 0.41 | 0.22 |”
Meta-analysis B median has the wrong sign
MinorThe reported summary is for the weighted cognitive-category effects in Table 4. Its two middle values are −0.49 and −0.47, giving a median of −0.48, not 0.48.
Reported 0.48 · recomputed -0.48
“The mean weighted effect size was -0.48 (median = 0.48) with a standard deviation of 0.45.”
The age correlation is assigned to different outcomes
MinorThe results identify attention/concentration as the outcome of the sole significant age correlation; the discussion instead calls it an overall-effect correlation.
“one significant correlation between mean age and attention/concentration, r (8) = -.72,P < .05”
“The significant negative correlation, between age and overall effect size, suggests that improvement in attention/concentration after withdrawal decreases as age increases.”
Table 3 is not ordered by decreasing weighted effect
MinorThe table claims descending order, but verbal memory has a weighted effect of 0.36 and appears after motor control/performance at 0.21.
“listed in order of decreasing, weighted effect size, meta-analysis A”
“| Motor control/performance | 4 | 0.28 | 0.21 | 0.27 | | Verbal memory | 5 | 0.44 | 0.36 | 0.46 |”
Cites
Wasserman, S. S., Hedges, L. V., & Olkin, I. (1988) · Journal of Educational Statistics · doi:10.2307/1164953 · Cited by 10,347 · see citing works
A compendium of neuropsychological tests: administration, norms, and commentary
(1991) · Choice Reviews Online · doi:10.5860/choice.29-2400 · Cited by 6,117 · see citing works
(1995) · Cited by 2,809 · see citing works
Cognitive Effects of Long-Term Benzodiazepine Use: A Meta-Analysis
Barker, M. J., Greenwood, K. M., Jackson, M., & Crowe, S. F. (2004) · CNS Drugs · doi:10.2165/00023210-200418010-00004 · Cited by 552 · see citing works
Self-citationChronic use of benzodiazepines and psychomotor and cognitive test performance
Lucki, I., Rickels, K., & Geller, A. (1986) · Psychopharmacology · doi:10.1007/bf00178503 · Cited by 186 · see citing works
Cognitive impairment in long-term benzodiazepine users
Golombok, S., Moodley, P., & Lader, M. (1988) · Psychological Medicine · doi:10.1017/s0033291700007911 · Cited by 167 · see citing works
A cross-national comparison of anti-anxiety/sedative drug use
Baker, M. B., Manheimer, D. I., Mellinger, G. D., & UHLENHUTH, E. H. (1984) · Current Medical Research and Opinion · doi:10.1185/03007998409109541 · Cited by 158 · see citing works
Advances in statistical methods for meta‐analysis
Hedges, L. V. (1984) · New Directions for Program Evaluation · doi:10.1002/ev.1376 · Cited by 142 · see citing works
Cognitive improvement following benzodiazepine discontinuation in elderly nursing home residents
Salzman, C., Fisher, J., Nobel, K., Glassman, R., Wolfson, A., & Kelley, M. (1992) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.930070205 · Cited by 117 · see citing works
Lack of cognitive recovery following withdrawal from long-term benzodiazepine use
Tata, P. R., Rollings, J., Collins, M., Pickering, A., & Jacobson, R. R. (1994) · Psychological Medicine · doi:10.1017/s0033291700026969 · Cited by 97 · see citing works
Psychometric performance during withdrawal from long-term benzodiazepine treatment
Petursson, H., Gudjonsson, G. H., & Lader, M. H. (1983) · Psychopharmacology · doi:10.1007/bf00427575 · Cited by 62 · see citing works
Wilson, L. G., Roberts, R. W., Gerber, C. J., & Johnson, M. H. (1982) · PubMed · Cited by 60 · see citing works
Curran, H. V., Bond, A., O'Sullivan, G., Bruce, M., Marks, I., Lelliot, P., Shine, P., & Lader, M. (1994) · Psychological Medicine · doi:10.1017/s0033291700029056 · Cited by 54 · see citing works
Neuropsychological impairment and exclusive abuse of sedatives or hypnotics
Bergman, H., Borg, S., & Holm, L. W. (1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.2.215 · Cited by 52 · see citing works
Aranko, K., Mj, M., & Seppälä, T. T. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02088.x · Cited by 52 · see citing works
Rickels, K., Lucki, I., Schweizer, E., Garcia-Espana, F., & Case, W. G. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199904000-00003 · Cited by 49 · see citing works
BERGMAN, H., BORG, S., ENGELBREKTSON, K., & VIKANDER, B. (1989) · British Journal of Addiction · doi:10.1111/j.1360-0443.1989.tb00612.x · Cited by 46 · see citing works
ADVERSE EFFECTS OF PROLONGED BENZODIAZEPINE USE
Ashton, H. (1986) · Adverse Drug Reaction Bulletin · doi:10.1097/00012995-198606000-00001 · Cited by 45 · see citing works
Differential acute psychomotor and cognitive effects of diazepam on long-term benzodiazepine users
Gorenstein, C., Bernik, M., & Pompéia, S. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199409000-00002 · Cited by 45 · see citing works
Tönne, U., Hiltunen, A. J., Vikander, B., Engelbrektsson, K., Bergman, H., Bergman, I., Leifman, H., & Borg, S. (1995) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1995.tb09786.x · Cited by 40 · see citing works
Long-term effects of alprazolam on memory: a 3·5 year follow-up of agoraphobia/panic patients
Kılıç, C., Curran, H. V., Noshirvani, H., MARKS, I., & OĞLU, M. B. (1999) · Psychological Medicine · doi:10.1017/s003329179800734x · Cited by 38 · see citing works
Impairment of performance associated with long-term use of benzodiazepines
Gorenstein, C., Bernik, M. A., Pompéia, S., & Marcourakis, T. (1995) · Journal of Psychopharmacology · doi:10.1177/026988119500900404 · Cited by 38 · see citing works
Curran, H. V. (1992) · Journal of Psychopharmacology · doi:10.1177/026988119200600113 · Cited by 36 · cited 6× · see citing works
“Test Cognitive category Reference Critical Flicker Fusion Speed of processing Curran, Hindmarch, Wattis, and Shillingford (1990) Digit-Symbol-Substitution Test Psychomotor speed Wechsler (1981)”
BackgroundMethodInfluentialCritical flicker fusion in normal elderly subjects; a cross-sectional community study
Curran, S., Hindmarch, I., Wattis, J. P., & SHILLINGFORD, C. A. (1990) · Current Psychology · doi:10.1007/bf02686765 · Cited by 33 · see citing works
Psychomotor performance following the long-term use of benzodiazepines.
Lucki, I., Rickels, K., & Am, G. (1985) · PubMed · Cited by 32 · see citing works
Performance effects of diazepam during and after prolonged administration
Brosan, L., Broadbent, D. E., Nutt, D., & Broadbent, M. (1986) · Psychological Medicine · doi:10.1017/s0033291700010321 · Cited by 31 · see citing works
The behavioral effects of benzodiazepines following long-term use.
Lucki, I., & Rickels, K. (1986) · PubMed · Cited by 29 · see citing works
The effects of long-term benzodiazepine treatment and graded withdrawal on psychometric performance
Sakol, M., & Power, K. (1988) · Psychopharmacology · doi:10.1007/bf00212782 · Cited by 17 · see citing works
Cognitive effects of long-term benzodiazepine use: A meta-analysis
(20012085), M. B., (14706073), K. G., (18029494), M. J., & (13428231), S. C. (2004) · RMIT Research Repository (RMIT University Library) · Cited by 17 · see citing works
Golombok, S. E. (1989) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470040104 · Cited by 11 · see citing works
Benzodiazepines: Towards More Logical Use
Cooper, A. J. (1982) · Scottish Medical Journal · doi:10.1177/003693308202700407 · Cited by 10 · see citing works
Chronic use of benzodiazepines and cognitive deficit complaints: A risk factor study
Chaves, M. L. F., Bianchin, M., Peccin, S., Rotta, F., Jardim, C., Gianlupi, A., & Eidt, L. (1993) · The Italian Journal of Neurological Sciences · doi:10.1007/bf02339172 · Cited by 9 · see citing works
Long‐term benzodiazepine treatment: Is it ever justified?
Chen, Y., & Lader, M. (1990) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.470050403 · Cited by 9 · see citing works
Flagged first, then by citations
1 of the 34 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- [7]7. * , † Birzele, H. J. (1992). Benzodiazepine induced amnesia after long-term medication and during withdrawal. European Review of Applied Psychology, 42, 277-282.
- [21]21. Lader, M. H. (1982). Psychological effects of buspirone. Journal of Clinical Psychiatry, 43, 62-67.
Cited by
Sorted by citations
European guideline for the diagnosis and treatment of insomnia
Riemann, D., Baglioni, C., Bassetti, C., Bjorvatn, B., Dolenc Groselj, L., Ellis, J. G., Espie, C. A., Garcia‐Borreguero, D., Gjerstad, M., Gonçalves, M., et al. (2017) · Journal of Sleep Research · doi:10.1111/jsr.12594 · Cited by 2,049 · see citing works
“long-term BZ use, one meta-analysis showed that negative effects might last up to 6 months (Barker et al., 2004).”
Management of Depression in Older Adults: A Review
Kok, R. M., & Reynolds, C. F. (2017) · JAMA · doi:10.1001/jama.2017.5706 · Cited by 890 · see citing works
Sleep, insomnia, and depression
Riemann, D. W., Krone, L. B., Wulff, K., & Nissen, C. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0411-y · Cited by 863 · see citing works
The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023
Riemann, D., Espie, C. A., Altena, E., Arnardottir, E. S., Baglioni, C., Bassetti, C. L. A., Bastien, C., Berzina, N., Bjorvatn, B., Dikeos, D., et al. (2023) · Journal of Sleep Research · doi:10.1111/jsr.14035 · Cited by 834 · see citing works
“…and dependence, nocturnal confusion and falls (Treves et al., 2018), negative effects on cognitive functioning including memory impairment (Barker et al., 2004; Stranks & Crowe, 2014), hangover effects with associated impairments in driving capability, especially from substances with long…”
BackgroundOutcome from mild traumatic brain injury
Iverson, G. L. (2005) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000165601.29047.ae · Cited by 694 · see citing works
Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics
Riss, J., Cloyd, J., Gates, J., & Collins, S. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01004.x · Cited by 511 · see citing works
The diagnosis and management of benzodiazepine dependence
Ashton, H. (2005) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000165594.60434.84 · Cited by 455 · see citing works
“Improvement occurs when the drugs are stopped, but it may be slow and perhaps incomplete [ 20 ,21].”
BackgroundMcCrea, M., Iverson, G. L., McAllister, T. W., Hammeke, T. A., Powell, M. R., Barr, W., & Kelly, J. P. (2009) · The Clinical Neuropsychologist · doi:10.1080/13854040903074652 · Cited by 417 · see citing works
“Benzodiazepine withdrawal (Barker, Greenwood, Jackson, & Crowe, 2004b ): 10 studies, long-term follow-up, 44 comparisons.”
Neurochemistry in the pathophysiology of autism.
McDougle, C. J., Erickson, C. A., Stigler, K. A., & Posey, D. J. (2005) · PubMed · Cited by 408 · see citing works
Scott, J. C., Slomiak, S. T., Jones, J. D., Rosen, A. F. G., Moore, T. M., & Gur, R. C. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.0335 · Cited by 391 · see citing works
S3-Leitlinie Nicht erholsamer Schlaf/Schlafstörungen
Riemann, D. W., Baum, E., Cohrs, S., Crönlein, T., Hajak, G., Hertenstein, E., Klose, P., Langhorst, J., Mayer, G., Nissen, C., et al. (2017) · Somnologie - Schlafforschung und Schlafmedizin · doi:10.1007/s11818-016-0097-x · Cited by 339 · see citing works
“nach dem Absetzen von Langzeit-Benzodiazepingebrauch weist darauf hin, dass die Effekte bei einigen Patienten länger als 6 Monate anhalten [188].”
BackgroundSleep Disturbances in Patients with Post-Traumatic Stress Disorder
Maher, M. J., Rego, S. A., & Asnis, G. M. (2006) · CNS Drugs · doi:10.2165/00023210-200620070-00003 · Cited by 337 · see citing works
Benzodiazepine Use in Older Adults: Dangers, Management, and Alternative Therapies
Markota, M., Rummans, T. A., Bostwick, J. M., & Lapid, M. I. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.07.024 · Cited by 307 · see citing works
“Several studies have indicated that even after benzodiazepines are discontinued, the cognitive function of long-term users continues to be impaired in most cognitive domains, suggesting lasting and possibly irreversible cognitive deficits associated with benzodiazepine use.(13,14) The overall effect sizes of such pote…”
BackgroundKurko, T., Saastamoinen, L., Tähkäpää, S.-M., Tuulio‐Henriksson, A., Taiminen, T. J., Tiihonen, J., Airaksinen, M., & Hietala, J. A. (2015) · European Psychiatry · doi:10.1016/j.eurpsy.2015.09.003 · Cited by 283 · see citing works
“Does it mean use defined by the development of tolerance, use beyond the recommended period in guidelines or use longer than an arbitrary time limit, such as one year? Regardless of extensive research on long-term BZD use, the existing evidence is difficult to evaluate because of conflicting results, study designs and…”
BackgroundThe Residual Medium and Long-term Cognitive Effects of Benzodiazepine Use: An Updated Meta-analysis
Crowe, S. F., & Stranks, E. K. (2018) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acx120 · Cited by 209 · see citing works
A Review of Alprazolam Use, Misuse, and Withdrawal
Ait-Daoud, N., Hamby, A. S., Sharma, S., & Blevins, D. (2018) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000350 · Cited by 195 · see citing works
“Furthermore, the degree of cognitive recovery that may take place after a benzodiazepine taper is unclear, with compelling evidence not supporting full restitution of cognitive function, at least in the first 6 months after cessation, and suggestion that there may be some permanent deficits in comparison to controls (…”
Neurosteroids and GABA-A Receptor Function
Wang, M. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00044 · Cited by 199 · see citing works
“, benzodiazepines (Barker et al., 2004), barbiturates (Mohammed et al.”
BackgroundVinkers, C. H., & Olivier, B. (2012) · Advances in Pharmacological Sciences · doi:10.1155/2012/416864 · Cited by 195 · see citing works
Chen, P.-L., Lee, W., Sun, W., Oyang, Y., & Fuh, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049113 · Cited by 177 · see citing works
Insomnia in Elderly Patients: Recommendations for Pharmacological Management
Abad, V. C., & Guilleminault, C. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0569-8 · Cited by 174 · see citing works
Benzodiazepine use and risk of dementia: evidence from the Caerphilly Prospective Study (CaPS)
Gallacher, J., Elwood, P., Pickering, J. E., Bayer, A. J., Fish, M., & Ben‐Shlomo, Y. (2011) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2011-200314 · Cited by 151 · see citing works
“A third strain of evidence comes from pharmacological studies that have identified acute adverse cognitive effects of benzodiazepine use in older persons,(1) 12 which may persist for over 6 months after withdrawal of medication.(13) Further evidence is therefore required to establish whether benzodiazepine use has any…”
BackgroundNeuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems
Birzniece, V., Bäckström, T. C., Johansson, I., Lindblad, C., Lundgren, P., Löfgren, M., Olsson, T., Ragagnin, G., Taube, M., Türkmen, Ş., et al. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.11.001 · Cited by 150 · see citing works
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148 · see citing works
“The long-term BZ effect was clearer when the reversal of cognitive impairment in different domains of neuropsychological tests was monitored during withdrawal from prolonged BZ use (Barker et al., 2004b).”
BackgroundMethodZebrafish models to study drug abuse-related phenotypes
Stewart, A., Wong, K., Jonathan Cachat, P., Gaikwad, S., Kyzar, E., Wu, N., Hart, P., Piet, V., Utterback, E., Elegante, M., et al. (2011) · Reviews in the Neurosciences · doi:10.1515/rns.2011.011 · Cited by 141 · see citing works
“Because cognitive defi cits commonly accompany drug abuse (Figure 1 ) (Barker et al. , 2004 ; Kelley et al. , 2005 ; Rogers et al. , 2005 ; Rapeli et al. , 2006 ), the ability to quantify both affective and cognitive phenomena in zebrafi sh becomes important to study in relation to drug abuse…”
BackgroundTHC and CBD: Similarities and differences between siblings
Stella, N. (2023) · Neuron · doi:10.1016/j.neuron.2022.12.022 · Cited by 149 · see citing works
Wu, C., Wang, S.-C., Chang, I., & Lin, K. (2009) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181a65210 · Cited by 144 · see citing works
Sirdifield, C., Anthierens, S., Creupelandt, H., Chipchase, S. Y., Christiaens, T., & Siriwardena, A. N. (2013) · BMC Family Practice · doi:10.1186/1471-2296-14-191 · Cited by 131 · see citing works
“They have considerable adverse effects including memory disruption, increased risk of accidents and falls, and dependence [1,2].”
BackgroundEAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke
Bassetti, C. L. A., Randerath, W., Vignatelli, L., Ferini-Strambi, L., Brill, A.-K., Bonsignore, M. R., Grote, L., Jennum, P., Leys, D., Minnerup, J., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.01104-2019 · Cited by 132 · see citing works
Ethical Issues Associated With the Assessment of Exaggeration, Poor Effort, and Malingering
Iverson, G. L. (2006) · Applied Neuropsychology · doi:10.1207/s15324826an1302_3 · Cited by 124 · see citing works
Vicens, C., Bejarano, F., Sempere, E., Mateu, C., Fiol, F., Socias, I., Aragonès, E., Palop, V., Beltran, J. L., Piñol, J. L., et al. (2014) · British Journal of Psychiatry · doi:10.1192/bjp.bp.113.134650 · Cited by 122 · see citing works
“26 General practitioners usually have limited time for consultations with each patient and often encounter difficulties in managing withdrawal.”
Siriwardena, A., Qureshi, M., Dyas, J., Middleton, H., & Orner, R. (2008) · The British journal of general practice : the journal of the Royal College of General Practitioners · doi:10.3399/bjgp08x299290 · Cited by 106 · see citing works
Management of chronic insomnia in elderly persons.
Bain, K. (2006) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2006.06.006 · Cited by 124 · see citing works
Manthey, L., van Veen, T., Giltay, E. J., Stoop, J. E., Neven, A. K., Penninx, B. W. J. H., & Zitman, F. G. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03818.x · Cited by 113 · see citing works
EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke
Bassetti, C. L. A., Randerath, W., Vignatelli, L., Ferini‐Strambi, L., Brill, A. ‐., Bonsignore, M. R., Grote, L., Jennum, P., Leys, D., Minnerup, J., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14201 · Cited by 109 · see citing works
Moritz, S., Pfuhl, G., Lüdtke, T., Menon, M., Balzan, R. P., & Andreou, C. (2016) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/j.jbtep.2016.07.004 · Cited by 99 · see citing works
Rapeli, P., Fabritius, C., Alho, H., Salaspuro, M. P., Wahlbeck, K., & Kalska, H. (2007) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-7-5 · Cited by 105 · see citing works
The Effects of Fall-Risk-Increasing Drugs on Postural Control: A Literature Review
de Groot, M. H., van Campen, J. P. C. M., Moek, M. A., Tulner, L. R., Beijnen, J. H., & Lamoth, C. J. C. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0113-9 · Cited by 97 · see citing works
“Interestingly, the adverse effects of FRIDs have been reported to be reversible, for postural control [161, 162], cognition [169], and for fall incidents [11–14].”
BackgroundThe Effect of Sleep Medications on Cognitive Recovery From Traumatic Brain Injury
Larson, E. B., & Zollman, F. S. (2010) · Journal of Head Trauma Rehabilitation · doi:10.1097/htr.0b013e3181c1d1e1 · Cited by 97 · see citing works
Ellul, J., Archer, N. J., Foy, C. M. L., Poppe, M., Boothby, H., Nicholas, H., Brown, R. G., & Lovestone, S. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.104034 · Cited by 91 · see citing works
The Role of Benzodiazepines in the Treatment of Epilepsy
Ochoa, J. G., & Kilgo, W. A. (2016) · Current Treatment Options in Neurology · doi:10.1007/s11940-016-0401-x · Cited by 88 · see citing works
Persistent post-traumatic headache: a migrainous loop or not? The clinical evidence
Labastida‐Ramírez, A., Benemei, S., Albanese, M., D’Amico, A., Grillo, G., Grosu, O., Ertem, D. H., Mecklenburg, J., Fedorova, E. P., Řehulka, P., et al. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01122-5 · Cited by 77 · see citing works
“current use of benzodiazepines for indications such as anxiety, muscle spasm, or insomnia may also aggravate posttraumatic cognitive symptoms (even after discontinuation) as well as depression and should, therefore, be avoided when possible [139, 140].”
BackgroundEffect of Benzodiazepine Discontinuation on Dementia Risk
Wu, C., Ting, T., Wang, S.-C., Chang, I., & Lin, K. (2010) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181e049ca · Cited by 85 · see citing works
Neuropsychological functioning in adult anorexia nervosa: A meta-analysis
Stedal, K., Broomfield, C., Hay, P., Touyz, S. W., & Scherer, R. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.08.021 · Cited by 75 · see citing works
“…for, variables which have been demonstrated to influence neuropsychological test results – like anxiety (Ely et al., 2016), depression (Burt et al., 1995; Wilsdon and Wade, 2006), medication (Barker et al., 2004; Goldberg and Burdick, 2001) and intelligence quotient (Diaz-Asper et al., 2004).”
BackgroundWrocklage, K. M., Schweinsburg, B., Krystal, J., Trejo, M., Roy, A. M., Weisser, V. D., Moore, T. M., Southwick, S., & Scott, J. C. (2016) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617716000059 · Cited by 65 · see citing works
Rupprecht, R., Wetzel, C. H., Dorostkar, M. M., Herms, J. W., Albert, N. L., Schwarzbach, J. V., Schumacher, M., & Neumann, I. D. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01561-3 · Cited by 61 · see citing works
Long-Term Pharmacological Treatments of Anxiety Disorders: An Updated Systematic Review
Perna, G., Alciati, A., Riva, A., Micieli, W., & Caldirola, D. (2016) · Current Psychiatry Reports · doi:10.1007/s11920-016-0668-3 · Cited by 70 · see citing works
Capiau, A., Huys, L., van Poelgeest, E. P., van der Velde, N., Petrović, M., Somers, A., & the EuGMS Task, F. G. O. F. (2022) · European Geriatric Medicine · doi:10.1007/s41999-022-00731-4 · Cited by 70 · see citing works
“They can cause short-term cognitive deficits, especially in memory, learning and attention [54].”
Withdrawing Benzodiazepines in Patients With Anxiety Disorders
Lader, M., & Kyriacou, A. (2016) · Current Psychiatry Reports · doi:10.1007/s11920-015-0642-5 · Cited by 67 · see citing works
Iverson, G. L., & Lange, R. T. (2010) · Springer eBooks · doi:10.1007/978-0-387-76978-3_22 · Cited by 68 · see citing works
Modulating Oxidative Stress Relieves Stress-Induced Behavioral and Cognitive Impairments in Rats
Solanki, N., Salvi, A., Patki, G., & Salim, S. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx017 · Cited by 67 · see citing works
“Though these pharmacological interventions are regarded as the “gold standard” of treatment, these are associated with severe side effects including, but not limited to, tolerance, withdrawal effects, memory dysfunction, and significant weight gain (Gudex, 1991; Ashton, 1994; Trindade et al., 1998; Ferguson, 2001; Bar…”
BackgroundFiorillo, A., Dell’Osso, B. M., Albert, U., Atti, A. R., Carmassi, C., Carrà, G., Cosci, F., Vecchio, V. D., Nicola, M. D., Ferrari, S., et al. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s83130 · Cited by 67 · see citing works
“230,231 The same study showed that these impairments persist well beyond cessation of BDZ use.”
Mura, T., Proust‐Lima, C., Akbaraly, T. N., Amieva, H., Tzourio, C., Chevassus, H., Picot, M., Jacqmin‐Gadda, H., & Berr, C. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.05.004 · Cited by 68 · see citing works
“Furthermore, despite the possible recovery of cognitive functions after withdrawal from longterm benzodiazepine use, this recovery after withdrawal could be incomplete with some remaining impairment in some areas of cognition (Barker et al., 2004).”
Agonist substitution—a treatment alternative for high‐dose benzodiazepine‐dependent patients?
Liebrenz, M., Boesch, L., Stohler, R., & Caflisch, C. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.02933.x · Cited by 66 · see citing works
Wu, M., Qiu, X., Chen, C., et al. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.140392 · Cited by 64 · see citing works
Multifocal Cognitive Dysfunction in High-Dose Benzodiazepine Users: A Cross-Sectional Study
Federico, A., Tamburin, S., Maier, A., Faccini, M., Casari, R., Morbioli, L., & Lugoboni, F. (2017) · Neurological Sciences · doi:10.1007/s10072-016-2732-5 · Cited by 60 · see citing works
“However, a direct cause–effect relationship between BZDs and cognitive dysfunction is blurred by the inclusion of patients with pre-existing cognitive and/or psychiatric conditions [2, 3], the persistence of cognitive effects after BZD withdrawal [15], and the hypothesis that longterm BZD users may have increased risk…”
BackgroundNeuropsychiatric Effects of Prescription Drug Abuse
Caplan, J. P., Epstein, L. A., Quinn, D. K., Stevens, J. R., & Stern, T. A. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9037-7 · Cited by 60 · see citing works
“Neuropsychiatric Effects of Prolonged Addiction Neuropsychiatric effects of sedative-hypnotic addiction include deficits in memory, motor coordination, visuospatial learning, processing speed, and verbal learning, even after drug discontinuation (Barker et al. 2004a; Bateson 2002; Stewart 2005).”
BackgroundSys, J., Cleynenbreugel, S. V., Deschodt, M., der Linden, L. R. V., & Tournoy, J. (2019) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-019-02812-z · Cited by 54 · see citing works
Models of anxiety: Responses of mice to novelty and open spaces in a 3D maze
Ennaceur, A., Michalíková, S., VANRENSBURG, R., & Chazot, P. L. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.07.001 · Cited by 54 · see citing works
Benzodiazepines in Alzheimer’s disease: beneficial or detrimental effects
Al-Kuraishy, H. M., Al-Gareeb, A. I., Saad, . M., & Batiha, G. E. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-01099-4 · Cited by 51 · see citing works
“However, according to clinical experiences and meta-analysis, discontinuation of BDZs may attenuate memory impairment in AD patients (Barker et al. 2004).”
BackgroundEffects of the use of hypnotics on cognition
Vermeeren, A., & Coenen, A. M. L. (2011) · Progress in brain research · doi:10.1016/b978-0-444-53817-8.00005-0 · Cited by 53 · see citing works
An evaluation of persisting cognitive effects after withdrawal from long-term benzodiazepine use
BARKER, M. J., GREENWOOD, K. M., JACKSON, M., & CROWE, S. F. (2005) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617705050332 · Cited by 53 · see citing works
“Because the feasibility of large-scale studies examining a wide variety of cognitive areas is questionable, we have previously argued the need for a number of smaller, wellcontrolled studies, which present their data in a manner amenable to future meta-analysis (Barker et al., 2004a).”
BackgroundMethodResultInfluentialSelf-citationCurrent and Potential Pharmacologic Therapies for Traumatic Brain Injury
Tani, J., Wen, Y.-T., Hu, C., & Sung, J. (2022) · Pharmaceuticals · doi:10.3390/ph15070838 · Cited by 56 · see citing works
“Benzodiazepines and Zolpidem Benzodiazepines are associated with attentional and memory impairments in TBI, and are generally to be avoided [86,87].”
BackgroundTen Wolde, G. B., Dijkstra, A., Van Empelen, P., Van Den Hout, W., Knuistingh Neven, A., & Zitman, F. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02141.x · Cited by 52 · see citing works
Rupprecht, R., Pradhan, A. K., Kufner, M., Brunner, L.-M., Nothdurfter, C., Wein, S., Schwarzbach, J. V., Puig-Bosch, X., Rupprecht, C., & Rammes, G. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-022-01532-3 · Cited by 43 · see citing works
“These observations are also reflected by findings in humans that long-term benzodiazepine use may cause cognitive deficits under clinical conditions [76, 77].”
BackgroundMemory Deficit Recovery after Chronic Vanadium Exposure in Mice
Folarin, O. R., Olopade, F. E., Onwuka, S. K., et al. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/4860582 · Cited by 51 · see citing works
“[29] reported that previous benzodiazepine users will likely experience benefits of improved cognitive functioning after withdrawal but will not experience full restitution of functions; similarly, deficits resulting from vanadium exposure though reversible could take a long time before full restitution is obtained.”
BackgroundD’Alessio, L., Korman, G. P., Sarudiansky, M., Guelman, L. R., Scévola, L., Pastore, A., Obregón, A., & Ej, R. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00501 · Cited by 53 · see citing works
The effects of guided discontinuation of antipsychotics on neurocognition in first onset psychosis
Faber, G., Smid, H. G. O. M., Gool, A. R. V., Wiersma, D., & van den Bosch, R. J. (2011) · European Psychiatry · doi:10.1016/j.eurpsy.2011.02.003 · Cited by 50 · see citing works
“Also, the use of other medication and specifically benzodiazepines, that could have influenced the results [2], was limited and did not favour the GD group.”
Persistent post-traumatic headache: a migrainous loop or not? The preclinical evidence
Benemei, S., Labastida‐Ramírez, A., Абрамова, Е. А., Brunelli, N., Caronna, E., Diana, P., Андреевич, Г. Р., Hofacker, M. D., Maestrini, I., Martínez‐Pías, E., et al. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01135-0 · Cited by 49 · see citing works
Fond, G. B., Berna, F. S., Boyer, L., Godin, O., Brunel, L., Andrianarisoa, M., Aouizerate, B., Capdevielle, D., Chéreau, I., Danion, J., et al. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0787-9 · Cited by 51 · see citing works
“Future longitudinal studies should confirm that BLTA withdrawal is associated with cognitive improvement, which has been suggested in one previous study [7].”
BackgroundResultBäckström, T. C., Das, R., & Bixo, M. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.13013 · Cited by 43 · see citing works
Baandrup, L., Fagerlund, B., & Glenthoj, B. Y. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0711-8 · Cited by 45 · see citing works
Shared and Distinct Neurocognitive Endophenotypes of Schizophrenia and Psychotic Bipolar Disorder
Kim, D., Kim, J., Koo, T., Yun, H., & Won, S. (2015) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2015.13.1.94 · Cited by 46 · see citing works
Rapeli, P., Fabritius, C., Kalska, H., & Alho, H. (2009) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/1747-597x-4-6 · Cited by 45 · see citing works
Mechanisms of Neurologic Failure in Critical Illness
Pustavoitau, A., & Stevens, R. D. (2008) · Critical Care Clinics · doi:10.1016/j.ccc.2007.11.004 · Cited by 44 · see citing works
“In non-ICU patients, prolonged treatment (O 1 year) with benzodiazepines may lead to decreased cognitive function that does not return to baseline after discontinuation of the drug [144].”
BackgroundTolerance development to Morris water maze test impairments induced by acute allopregnanolone
Türkmen, Ş., Löfgren, M., Birzniece, V., Bäckström, T. C., & Johansson, I. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.12.031 · Cited by 43 · see citing works
Psychopharmacology of traumatic brain injury
Polich, G. R., Iaccarino, M. A., & ZAFONTE, R. D. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64012-3.00015-0 · Cited by 42 · see citing works
Identifying Exaggeration and Malingering
Iverson, G. L. (2007) · Pain Practice · doi:10.1111/j.1533-2500.2007.00116.x · Cited by 44 · see citing works
Insights on benzodiazepines' potential in Alzheimer's disease
Al-Kuraishy, H. M., Al-Gareeb, A. I., Alsayegh, A. A., Abusudah, W. F., Almohmadi, N. H., Eldahshan, O. A., Ahmed, E., & Batiha, G. E. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121532 · Cited by 44 · see citing works
Fisher, J. E., Sanyal, C., Frail, D. M., & SKETRIS, I. S. (2011) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2011.01245.x · Cited by 41 · see citing works
“Furthermore, short-term BZD use may be safe and effective but long-term use at normal therapeutic doses is associated with a high risk of dependence and withdrawal symptoms upon discontinuation.(1,4,10) Despite the associated risks, several population-based epidemiological studies have reported prevalence rates of BZD…”
BackgroundFirst- and second-generation antipsychotic medication and cognitive processing in schizophrenia
Weickert, T. W., & Goldberg, T. E. (2005) · Current Psychiatry Reports · doi:10.1007/s11920-005-0085-5 · Cited by 41 · see citing works
“... treatment of anxiety or sedation, may have a negative impact on cognition in patients with schizophrenia because verbal memory, speed of processing, motor control and/or performance, working memory, visuospatial ability, and general intelligence all have been shown to be adversely influenced by prolonged administr…”
BackgroundCognitive disorders in epilepsy II: Clinical targets, indications and selection of test instruments
Helmstaedter, C., Sadat-Hossieny, Z., Kanner, A. M., & Meador, K. J. (2020) · Seizure · doi:10.1016/j.seizure.2020.09.031 · Cited by 42 · see citing works
Is Long-Term Benzodiazepine Use a Risk Factor for Cognitive Decline? Results of a Systematic Review
Nader, D. A., & Gowing, L. (2020) · Journal of Addiction · doi:10.1155/2020/1569456 · Cited by 44 · see citing works
“that there is an association between current [11] or previous [12] long-term BZD use and cognitive impairment.”
BackgroundPuustinen, J., Lähteenmäki, R., Polo‐Kantola, P., Salo, P., Vahlberg, T. J., Lyles, A., Neuvonen, P. J., Partinen, M., Räihä, I. J., & Kivelä, S.-L. (2013) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-013-1613-6 · Cited by 41 · see citing works
Executive function in eating disorders: The role of state anxiety
Billingsley‐Marshall, R. L., Basso, M. R., Lund, B. C., Hernandez, E. R., Johnson, C. L., Drevets, W. C., McKee, P. A., & Yates, W. R. (2013) · International Journal of Eating Disorders · doi:10.1002/eat.22086 · Cited by 40 · see citing works
Puustinen, J., Nurminen, J., Kukola, M., Vahlberg, T. J., Laine, K., & Kivelä, S. (2007) · Drugs & Aging · doi:10.2165/00002512-200724120-00007 · Cited by 40 · see citing works
Who Gets Head Trauma or Recruited in Mild Traumatic Brain Injury Research?
Isokuortti, H., Iverson, G. L., Kataja, A., Brander, A., Öhman, J. E., & Luoto, T. M. (2015) · Journal of Neurotrauma · doi:10.1089/neu.2015.3888 · Cited by 36 · see citing works
Kitajima, R., Miyamoto, S., Tenjin, T., Ojima, K., Ogino, S., Miyake, N., Fujiwara, K., Funamoto, Y., Arai, J., Tsukahara, S., et al. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.11.008 · Cited by 37 · see citing works
“BZDs have anxiolytic, sedative, hypnotic, skeletal muscle relaxant, and anticonvulsant effects (Ashton, 1994; Barker et al., 2004a).”
BackgroundThe effect of alcohol withdrawal syndrome severity on sleep, brain and cognition
Lanièpce, A., Cabé, N., André, C., Bertran, F., Boudehent, C., Lahbairi, N., Maillard, A., Mary, A., Segobin, S. H., Vabret, F., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa123 · Cited by 40 · see citing works
Lou, B. X., & Oks, M. (2021) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2021.04.003 · Cited by 32 · see citing works
Huhtaniska, S., Jääskeläinen, E., Heikka, T., Moilanen, J. S., Lehtiniemi, H., Tohka, J., Manjón, J. V., Pierrick Coupé, A., Björnholm, L., Koponen, H., et al. (2017) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2017.05.009 · Cited by 34 · see citing works
“…associated with increased risk of mortality even after controlling for potential confounders (Fontanella et al., 2016) and, in general, benzodiazepine use has been associated with not only increased mortality (Tiihonen et al., 2016) but also cognitive impairment (Barker et al., 2005, 2004a, 2004b).”
Lähteenmäki, R., Neuvonen, P. J., Puustinen, J., Vahlberg, T., Partinen, M., Räihä, I., & Kivelä, S. (2019) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13144 · Cited by 34 · see citing works
“Chronic BZDA use in older adults is associated with an increased risk of adverse outcome such as balance difficulties, falling, cognitive impairment, dementia and increased mortality.(5-13) Various strategies have been applied to improve the quality of hypnotic prescription and to withdraw BZDA hypnotics from their ch…”
BackgroundThe Relationship between Sleep Complaints, Depression, and Executive Functions on Older Adults
de Almondes, K. M., Costa, M. V., Malloy‐Diniz, L. F., & Diniz, B. S. (2016) · Frontiers in Psychology · doi:10.3389/fpsyg.2016.01547 · Cited by 34 · see citing works
“Previous studies have also found association between attention and use of benzodiazepines (Barker et al., 2004) that could be due to inductive sedation effect (Chennu and Bekinschtein, 2012).”
BackgroundLee, J. Y., Farrell, B., & Holbrook, A. M. (2018) · Polish Archives of Internal Medicine · doi:10.20452/pamw.4391 · Cited by 32 · see citing works
García, M. Á. F., Lima, A. O. D. L., López, I. F., & Bermúdez‐Tamayo, C. (2018) · Journal of Pharmaceutical Policy and Practice · doi:10.1186/s40545-017-0128-4 · Cited by 33 · see citing works
“As evidence-based clinical guidelines [1] on BZD use are not being applied in clinical practice, we saw the need for an analysis of how prescribing trends have changed over recent years.”
BackgroundDavies, S., Jacob, B. J., Rudoler, D., Zaheer, J., de Oliveira, C., & Kurdyak, P. A. (2017) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125317743651 · Cited by 30 · see citing works
Monocausal attribution and its relationship with reasoning biases in schizophrenia
Moritz, S., Bentall, R. P., Kolbeck, K., & Roesch-Ely, D. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.06.057 · Cited by 28 · see citing works
“Evidence for severe neuropsychological impairment has become equivocal as poor cognitive test results partially reflect the effects of psychotropic medication and poor motivation (Barker et al., 2004; Faber et al., 2012; Fervaha et al., 2014; Moritz et al., 2017).”
BackgroundMemory dysfunction in panic disorder: an investigation of the role of chronic benzodiazepine use
Deckersbach, T., Moshier, S. J., Tuschen‐Caffier, B., & Otto, M. W. (2011) · Depression and Anxiety · doi:10.1002/da.20891 · Cited by 30 · see citing works
“Furthermore, one meta-analysis suggests that although cognitive impairment lessens following withdrawal, patients continue to demonstrate some impairment compared to healthy individuals.[10] One serious challenge to the interpretation of these findings is that studies of long-term benzodiazepine use are potentially co…”
BackgroundDo Benzodiazepines Cause Alzheimer’s Disease?
Salzman, C. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20040375 · Cited by 31 · see citing works
Dependence on Prescription Benzodiazepines and Z-drugs Among Young to Middle-aged Patients in France
Guerlais, M., Grall‐Bronnec, M., Feuillet, F., Gérardin, M., Jolliet, P., & Victorri‐Vigneau, C. (2014) · Substance Use & Misuse · doi:10.3109/10826084.2014.980952 · Cited by 29 · see citing works
Greten, S., Müller-Funogea, J. I., Wegner, F., Höglinger, G. U., Simon, N., Junius‐Walker, U., Gerbel, S., Krause, O., & Klietz, M. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02276-x · Cited by 27 · see citing works
- Authors
- Barker, M.
- Affiliations
- La Trobe University (AU)
- Corresponding author
- Barker, M
- Venue
- Archives of Clinical Neuropsychology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-04
- Volume
- 19
- Issue
- 3
- Pages
- 437-454
- ISSN
- 0887-6177 (ISSN-L)
- OpenAlex
- W2169064904
- Cited by
- 307
- References
- 34
- Citations by year
- 2026: 8 · 2025: 17 · 2024: 12 · 2023: 13 · 2022: 12 · 2021: 15 · 2020: 21 · 2019: 19 · 2018: 18 · 2017: 25 · 2016: 22 · 2015: 14 · 2014: 12 · 2013: 16 · 2012: 13
- FWCI
- 0.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Clinical Neuropsychology (publishedVersion)
- PubMed (publishedVersion)
- RMIT Research Repository (RMIT University Library) (submittedVersion)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- benzodiazepines, long-term benzodiazepine use, benzodiazepine withdrawal, cognitive impairment, cognitive recovery, residual cognitive deficits, benzodiazepine withdrawal syndrome
- MeSH terms
- Benzodiazepines, Clinical Trials as Topic, Cognition Disorders, Humans, Long-Term Care, Neuropsychological Tests, Psychometrics, Substance Withdrawal Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-11.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-11.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review